Beifang Li
- Cancer Research top 10%
- Cancer Genomics and Diagnostics 3
-
- Pancreatic and Hepatic Oncology Research 1
-
- Genetic factors in colorectal cancer 3
-
- Gastric Cancer Management and Outcomes 3
-
- Monoclonal and Polyclonal Antibodies Research 2
-
- Glycosylation and Glycoproteins Research 1
- Cancer therapeutics and mechanisms 1
-
- Bioactive Compounds and Antitumor Agents 1
- Journals
- European Journal of Cancer (1 paper)International Journal of Biological Macromolecules (1 paper)Cell Death and Disease (2 papers)
- Partner nations
- ChinaUnited StatesEthiopia
In The Last Decade
Beifang Li
11 papers receiving 410 citations
Peers
Comparison fields: 5 of 65
- Cancer Research 186
- Oncology 142
- Pathology and Forensic Medicine 74
- Pulmonary and Respiratory Medicine 123
- Gastroenterology 17
Countries citing papers authored by Beifang Li
This map shows the geographic impact of Beifang Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beifang Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beifang Li more than expected).
Fields of papers citing papers by Beifang Li
This network shows the impact of papers produced by Beifang Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beifang Li. The network helps show where Beifang Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Beifang Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 24 | |
| 2 | 2022 | 7 | |
| 3 | 2022 | 19 | |
| 4 | 2019 | 23 | |
| 5 | 2019 | 20 | |
| 6 | 2018 | 84 | |
| 7 | 2017 | 50 | |
| 8 | 2017 | 74 | |
| 9 | 2017 | 15 | |
| 10 | Genomic alterations in advanced gastric cancer endoscopic biopsy samples using targeted next-generation sequencing. | 2017 | 39 |
| 11 | 2014 | 62 |
About Beifang Li
Beifang Li is a scholar working on Toxicology, Cancer Research and Pathology and Forensic Medicine, having authored 11 papers that have together received 417 indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (3 papers), Genetic factors in colorectal cancer (3 papers), Gastric Cancer Management and Outcomes (3 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Glycosylation and Glycoproteins Research (1 paper), Pancreatic and Hepatic Oncology Research (1 paper), Cancer therapeutics and mechanisms (1 paper) and Bioactive Compounds and Antitumor Agents (1 paper). The work is most often cited by research in Cancer Research (186 citations), Oncology (142 citations) and Pathology and Forensic Medicine (74 citations). Beifang Li has collaborated with scholars based in China, United States and Ethiopia. Frequent co-authors include Jing Gao, Zhongwu Li, Zhentao Liu, Lin Shen, Zuhua Chen, Yangchao Luo, Hai Wang, Bin Dong, Cheng Zhang and Ji‐Young Lee. Their work appears in journals such as European Journal of Cancer, International Journal of Biological Macromolecules and Cell Death and Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.